Barclays’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Barclays’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-88,521	Closed	-$1.39M	–	4386
2024 Q1	$1.39M	Sell	88,521 -76,592	-46%	-$1.2M	﹤0.01%	2185
2023 Q4	$2.66M	Buy	165,113 +51,072	+45%	+$824K	﹤0.01%	1959
2023 Q3	$1.45M	Sell	114,041 -27,554	-19%	-$351K	﹤0.01%	1859
2023 Q2	$1.99M	Buy	141,595 +16,026	+13%	+$226K	﹤0.01%	1742
2023 Q1	$1.94M	Sell	125,569 -42,770	-25%	-$661K	﹤0.01%	1675
2022 Q4	$2.76M	Buy	168,339 +12,109	+8%	+$199K	﹤0.01%	1444
2022 Q3	$2.89M	Buy	156,230 +114,082	+271%	+$2.11M	﹤0.01%	1418
2022 Q2	$554K	Sell	42,148 -138,226	-77%	-$1.82M	﹤0.01%	2502
2022 Q1	$1.67M	Buy	180,374 +40,091	+29%	+$372K	﹤0.01%	1918
2021 Q4	$1.37M	Buy	140,283 +76,704	+121%	+$750K	﹤0.01%	2014
2021 Q3	$2.16M	Buy	63,579 +33,186	+109%	+$1.13M	﹤0.01%	1815
2021 Q2	$1.11M	Sell	30,393 -59,974	-66%	-$2.19M	﹤0.01%	2052
2021 Q1	$4.05M	Buy	90,367 +37,057	+70%	+$1.66M	﹤0.01%	1347
2020 Q4	$3.04M	Buy	53,310 +32,563	+157%	+$1.86M	﹤0.01%	1319
2020 Q3	$1.06M	Sell	20,747 -22,053	-52%	-$1.13M	﹤0.01%	1882
2020 Q2	$2.56M	Sell	42,800 -15,120	-26%	-$903K	﹤0.01%	1303
2020 Q1	$2.39M	Buy	57,920 +26,512	+84%	+$1.09M	﹤0.01%	1253
2019 Q4	$1.96M	Sell	31,408 -2,140	-6%	-$133K	﹤0.01%	1900
2019 Q3	$1.14M	Buy	33,548 +23,967	+250%	+$813K	﹤0.01%	2177
2019 Q2	$216K	Sell	9,581 -482	-5%	-$10.9K	﹤0.01%	3155
2019 Q1	$234K	Sell	10,063 -3,845	-28%	-$89.4K	﹤0.01%	2961
2018 Q4	$292K	Buy	13,908 +9,073	+188%	+$190K	﹤0.01%	2555
2018 Q3	$188K	Buy	4,835 +3,706	+328%	+$144K	﹤0.01%	3102
2018 Q2	$44K	Sell	1,129 -3,116	-73%	-$121K	﹤0.01%	3327
2018 Q1	$86K	Buy	4,245 +2,937	+225%	+$59.5K	﹤0.01%	3235
2017 Q4	$30K	Sell	1,308 -23,692	-95%	-$543K	﹤0.01%	3561
2017 Q3	$475K	Buy	+25,000	New	+$475K	﹤0.01%	1949